These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 24963564)
21. An evaluation of spontaneous adverse drug reaction monitoring systems. Sachs RM; Bortnichak EA Am J Med; 1986 Nov; 81(5B):49-55. PubMed ID: 3789003 [TBL] [Abstract][Full Text] [Related]
22. Be WWWary of Internet drugs. Heart Advis; 2002 Aug; 5(8):4-5. PubMed ID: 12184289 [No Abstract] [Full Text] [Related]
23. The new Food and Drug Administration drug package insert: implications for patient safety and clinical care. Watson KT; Barash PG Anesth Analg; 2009 Jan; 108(1):211-8. PubMed ID: 19095852 [TBL] [Abstract][Full Text] [Related]
24. Accuracy and completeness of drug information in Wikipedia medication monographs. Reilly T; Jackson W; Berger V; Candelario D J Am Pharm Assoc (2003); 2017; 57(2):193-196.e1. PubMed ID: 27866956 [TBL] [Abstract][Full Text] [Related]
25. Direct-to-consumer prescription drug advertising. Terzian TV Am J Law Med; 1999; 25(1):149-67. PubMed ID: 10207573 [No Abstract] [Full Text] [Related]
26. Focus on: information technology. Online drug information for dermatology patients. Oakley A J Drugs Dermatol; 2005; 4(1):108-13. PubMed ID: 15696997 [TBL] [Abstract][Full Text] [Related]
27. Adverse-drug-reaction monitoring. Faich GA N Engl J Med; 1986 Jun; 314(24):1589-92. PubMed ID: 3713757 [No Abstract] [Full Text] [Related]
28. Classification and coding considerations for drug data base design. Forbes MB J Clin Comput; 1983; 12(3):88-100. PubMed ID: 10317426 [No Abstract] [Full Text] [Related]
29. Effects of FDA safety warnings may vary. Kuehn BM JAMA; 2012 Mar; 307(9):894-5. PubMed ID: 22396504 [No Abstract] [Full Text] [Related]
30. Patient package inserts: the proper prescription? Rowe HM Food Drug Law J; 1995; 50(1):95-124. PubMed ID: 10342988 [No Abstract] [Full Text] [Related]
32. Regulating manufacturer-affiliated communication in the information age. Schulman KA; Abernethy DR; Rathore SS; Woosley RL Clin Pharmacol Ther; 1999 Jun; 65(6):593-7. PubMed ID: 10391664 [No Abstract] [Full Text] [Related]
33. Pediatric information in drug product labeling. Sachs AN; Avant D; Lee CS; Rodriguez W; Murphy MD JAMA; 2012 May; 307(18):1914-5. PubMed ID: 22570457 [No Abstract] [Full Text] [Related]
34. Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium. Anthony M; Romero K; Malone DC; Hines LE; Higgins L; Woosley RL Clin Pharmacol Ther; 2009 Oct; 86(4):425-9. PubMed ID: 19587643 [TBL] [Abstract][Full Text] [Related]
35. FDA drug labeling: rich resources to facilitate precision medicine, drug safety, and regulatory science. Fang H; Harris SC; Liu Z; Zhou G; Zhang G; Xu J; Rosario L; Howard PC; Tong W Drug Discov Today; 2016 Oct; 21(10):1566-1570. PubMed ID: 27319291 [TBL] [Abstract][Full Text] [Related]
36. Keeping up with drug use and safety. Long CO Home Healthc Nurse; 2004 Aug; 22(8):530-1. PubMed ID: 15314556 [No Abstract] [Full Text] [Related]
37. Literacy demands of product information intended to supplement television direct-to-consumer prescription drug advertisements. Kaphingst KA; Rudd RE; DeJong W; Daltroy LH Patient Educ Couns; 2004 Nov; 55(2):293-300. PubMed ID: 15530767 [TBL] [Abstract][Full Text] [Related]
38. Adverse drug reactions. Shuttleworth A Nurs Times; 2006 Jul 25-31; 102(30):58. PubMed ID: 16903313 [No Abstract] [Full Text] [Related]
39. The medicolegal significance of the package insert. Hirsh HL Med Trial Tech Q; 1976; 23(2):143-50. PubMed ID: 1004155 [No Abstract] [Full Text] [Related]